Bharat Biotech's Covaxin found effective against all emerging COVID19 variants: Journal.
The Clinical Infectious Disease Journal, in a certain development, found that Bharat Biotech's COVAXIN is operative in counterbalancing the new popping up variants of COVID19. The journal said 'the made in India' vaccine is effective in neutralizing all key variants, including the double mutant strain that has been recognized in India and UK, B.1.617, and B.1.1.7, respectively.
"A modest reduction in neutralisation by a factor of 1.95 was observed against B.1.617 variant compared to vaccine variant (D614G). Despite the reduction, neutralising titre levels with B.1.617 remain above levels expected to be protective," the medical journal said.
The Union health minister, Mr. Harshvardhan, months back, has explained that Covaxin is more effective in working against the UK variant and the Indian variant.
NCB regional director Sameer Wankhede is not targeting Bollywood, his wife Kranti Redkar told India Today on Monday. He also responded to the allegati...
27th of October is observed as the Black Day. During this day India had invaded the disputed Jammu and Kashmir back in 1947.Alastair Lamb, in his book...